MortimerIL. Lessons from a Symposium on difficult treatment problems in respiratory disease held in the College on 25 October 1996Proc R Coll Physicians Edinb1997; 27:485–90.
2.
OverbeekSLKerstjensHAMBogaardJM. Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)?Chest1996; 110:35–41.
3.
BackmanKSGreenbergerPAPattersonR. Airways obstruction in patients with long-term asthma consistent with ‘irreversible asthma’Chest1997; 112:1234–40.
4.
EliassonODegraffAC. The use of criteria of reversibility and obstruction to define patient groups for bronchodilator trials. Am Rev Respir Dis1985; 132:858–64.
5.
PauwelsRALofdahlC-GPostmaDS. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med1997; 337:1405–11.
6.
Ramirez-VenegasAWardJLentineT. Salmeterol reduces dyspnoea and improves lung function in patients with COPD. Chest1997; 112:336–40.
7.
EvansDJTaylorDAZetterstromO. A comparison of low-dose budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med1997; 337:1412–8.
8.
MurcianoDAubierMLecocguicY. Effects of theophylline on diaphragmatic strength and fatigue in patients with chronic obstructive pulmonary disease. N Engl J Med1984; 311:34953.
9.
WeirDCBurgePS. Effects of a high dose inhaled beclomethasone dipropionate, 750mcg and 1500mcg twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction. Thorax1993; 48:309–16.
10.
KerstjensHAMBrandPLPHughesMD. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med1992; 327:1413–9.
